Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
about
Isolation, Detection, and Quantification of Cancer Biomarkers in HPV-Associated Malignancies.Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partnersHuman papillomavirus serology and tobacco smoking in a community control group.Current trends in the etiology and diagnosis of HPV-related head and neck cancers.HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.HPV-associated head and neck cancer: molecular and nano-scale markers for prognosis and therapeutic stratificationHPV detection methods in head and neck cancer.Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide.IgG4 subclass antibodies impair antitumor immunity in melanoma.Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.Application of flat panel OLED display technology for the point-of-care detection of circulating cancer biomarkersBiologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study.Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer.Autoantibodies in cancer: prognostic biomarkers and immune activation.Miniaturized immunoassays: moving beyond the microplate.Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: a review and summary of the literature.Proteomic Monitoring of B Cell Immunity.Programmable protein arrays for immunoprofiling HPV-associated cancers.Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer.Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.
P2860
Q30354272-638FCF81-D965-4A05-858A-7C1A731AFDA5Q33798618-9874B93D-AB6D-4FD7-AC56-711B6253B70BQ34682692-2AED1697-A844-434C-9FDD-44227C0A4A26Q34976629-4507CF37-0247-489E-BA94-3BD38B56B91DQ35469459-6DD70BE2-B031-4C79-AF61-E502327EA501Q35688600-1A17B2AE-F676-48D6-99EB-07AB85933FC2Q35750840-5AFBEE1F-F668-4733-8B1E-C799C6C53730Q35969807-ADD49FF7-705D-42D2-9E17-D0C79C977D2DQ36088064-DA88C732-DD1F-4751-BB1B-796AB1DECC74Q36099498-1941E8B6-8FA6-4121-9476-8857AC760B03Q36539497-1D435E2E-6AEF-4F8D-A806-F071A11D6AD7Q36630457-9A937D71-669D-4972-873E-444B986BDF97Q36733452-8C6509F1-4C3A-4C1E-918B-728D6183D8B2Q37004759-F02EE931-2E56-4C16-85E7-69EF257D2C92Q37061534-499DD39B-648B-4CDD-9B96-A0D29253AFF4Q37170267-69D428D9-906D-4CA7-B18C-B11FC2782F6AQ37290631-555A910E-1069-4E7D-AE75-F72FA0ED7FD2Q37945787-331FEE2C-14B3-44E6-A721-A617BB5ED5D8Q37976441-6CE8403C-6412-487C-A1A9-0BC21D081ECBQ37986696-E76F812F-7EFC-4EA8-90E5-73DA631E122DQ38807840-7A1C2F1B-A461-47E8-9EE3-6E48554F2EE4Q39842946-CA8F894E-35FC-476E-B700-154A21681B6FQ40045515-42C2F329-C3CD-48AD-AB59-8EE4CE9B2599Q40289265-55CBE87F-3BE5-486D-A3C4-F02146CD779BQ43777296-147A53FF-B19D-4250-979D-902E283570B1Q46015106-312FE3C2-2D63-42C4-B94A-33F7FDFB70F3Q47677262-614866E5-A8FD-47CE-AB12-52BE64DC3DD4Q50743511-0B4C8CD5-4D3C-41DD-BFB9-378B80F691CEQ53275556-A4B988CB-1C32-4C92-8564-2D7E80C68957
P2860
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
@ast
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
@en
type
label
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
@ast
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
@en
prefLabel
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
@ast
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
@en
P2093
P2860
P356
P1476
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
@en
P2093
J Longtine
K S Anderson
K T Kelsey
P2860
P2888
P304
P356
10.1038/BJC.2011.171
P407
P577
2011-06-01T00:00:00Z